Vaida Glatt

Vaida Glatt

Auto-generated profile, based on publicly available information

Vaida Glatt

Department of Orthopedic Surgery, University of Texas Health Science Center San Antonio, San Antonio, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2017 in Frontiers in Physiology
Verified
Journal Article
Open access
VGVaida Glatt
Vaida Glatt
CEChristopher H. Evans
Christopher H. Evans
KTKevin Tetsworth
Kevin Tetsworth
In order to achieve consistent and predictable fracture healing, a broad spectrum of growth factors are required to interact with one another in a highly organized response. Critically important, the mechanical environment around the fracture site will significantly influence the way bone heals or if it heals at all. The role of the various biological factors, the timing and spatial relationship of their introduction, and how the mechanical environment orchestrates this activity, are all crucial aspects to consider. This review will synthesize decades of work and the acquired knowledge that has been used to develop new treatments and technologies for the regeneration and healing of bone. Moreover, it will discuss the current state of the art in experimental and clinical studies concerning the application of these mechano-biological principles to enhance bone healing, by controlling the mechanical environment under which bone regeneration takes place. This includes everything from the basic principles of fracture healing, to the influence of mechanical forces on bone regeneration, and how this knowledge has influenced current clinical practice. Finally, it will examine the efforts now being made for the integration of this research together with the findings of complementary studies in biology, tissue engineering, and regenerative medicine. By bringing together these diverse disciplines in a cohesive manner, the potential exists to enhance fracture healing and ultimately improve clinical outcomes.

21 February 2017 in SICOT-J
Verified
Journal Article
Open access
PDF file
KTKevin Tetsworth
Kevin Tetsworth
SBSteve Block
Steve Block
VGVaida Glatt
Vaida Glatt
SICOT-J, official journal of the Société Internationale de Chirurgie Orthopédique et de Traumatologie (SICOT)

19 July 2021 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
LBLena Batoon
Lena Batoon
SMSusan M. Millard
Susan M. Millard
LRLiza J. Raggatt
Liza J. Raggatt
AWAndy C. Wu
Andy C. Wu
SKSimranpreet Kaur
Simranpreet Kaur
APAllison R. Pettit
Allison R. Pettit
Osteal macrophages (osteomacs) support osteoblast function and promote bone anabolism, but their contribution to osteoporosis has not been explored. Although mouse ovariectomy (OVX) models have been repeatedly used, variation in strain, experimental design and assessment modalities have contributed to no single model being confirmed as comprehensively replicating the full gamut of osteoporosis pathological manifestations. We validated an OVX model in adult C3H/HeJ mice and demonstrated that it presents with human postmenopausal osteoporosis features with reduced bone volume in axial and appendicular bone and bone loss in both trabecular and cortical bone including increased cortical porosity. Bone loss was associated with increased osteoclasts on trabecular and endocortical bone and decreased osteoblasts on trabecular bone. Importantly, this OVX model was characterized by delayed fracture healing. Using this validated model, we demonstrated that osteomacs are increased post-OVX on both trabecular and endocortical bone. Dual F4/80 (pan-macrophage marker) and tartrate-resistant acid phosphatase (TRAP) staining revealed osteomacs frequently located near TRAP+ osteoclasts and contained TRAP+ intracellular vesicles. Using an in vivo inducible macrophage depletion model that does not simultaneously deplete osteoclasts, we observed that osteomac loss was associated with elevated extracellular TRAP in bone marrow interstitium and increased serum TRAP. Using in vitro high-resolution confocal imaging of mixed osteoclast-macrophage cultures on bone substrate, we observed macrophages juxtaposed to osteoclast basolateral functional secretory domains scavenging degraded bone byproducts. These data demonstrate a role for osteomacs in supporting osteoclastic bone resorption through phagocytosis and sequestration of resorption byproducts. Overall, our data expose a novel role for osteomacs in supporting osteoclast function and provide the first evidence of their involvement in osteoporosis pathogenesis. © 2021 American Society for Bone and Mineral Research (ASBMR).

3 July 2020 in Journal of Orthopaedic Trauma
Verified
Journal Article
Closed access
KTKevin D Md Tetsworth
Kevin D Md Tetsworth
HBHenry G. Burnand
Henry G. Burnand
EHErik Hohmann
Erik Hohmann
VGVaida Glatt
Vaida Glatt
Objectives: To develop a post-traumatic bone defect classification scheme and complete a preliminary assessment of its reliability. Design: Retrospective classification. Setting: Tertiary referral trauma center. Patients/Participants: Twenty open fractures with bone loss. Intervention: Assignment of a bone defect classification grade. Main Outcome Measurements: Open fractures were classified based on orthogonal radiographs, assessing the extent and local geometry of bone loss, including D1—incomplete defects, D2—minor/subcritical (complete) defects (<2 cm), and D3—segmental/critical-sized defects (≥2 cm). Incomplete defects (D1) include D1A—75% cortical loss. Minor/subcritical (complete) defects (<2 cm) (D2) include D2A—2 oblique ends allowing for possible overlap, D2B—one end oblique/one end transverse, and D2C—2 transverse ends. Segmental/critical-sized Defects (≥2 cm) include D3A—moderate defects, 2 to <4 cm; D3B—major defects, 4 to <8 cm; and D3C—massive defects, ≥8 cm. Reliability was assessed among 3 independent observers using Fleiss' kappa tests. Results: Interobserver reliability demonstrated the classification scheme has very good agreement, κ = 0.8371, P < 0.0005. Intraobserver reliability was excellent, κ = 1.000 (standard error 0.1478–0.1634), P < 0.00001. Interobserver reliability for the distinction between categories alone (D1, D2, or D3) was also excellent, κ = 1.000 (standard error 0.1421–0.1679), P < 0.00001. Conclusions: This classification scheme provides a robust guide to bone defect assessment that can potentially facilitate selection of the most appropriate treatment strategy to optimize clinical outcomes.

1 March 2019 in OTA International
Verified
Journal Article
Open access
KTKevin Tetsworth
Kevin Tetsworth
AWAnna Woloszyk
Anna Woloszyk
VGVaida Glatt
Vaida Glatt
Introduction: Traumatic femoral segmental bone loss is a complex clinical problem, one that often requires extreme solutions. This study examines a new treatment strategy for segmental bone loss using patient-specific 3D printed titanium cages in conjunction with the Masquelet technique. Methods: The study was composed of a clinical observational case series, and a basic science investigation to evaluate the biological activity of the induced membranes using histology, immunohistochemistry (IHC), and gene expression analysis. Eligible patients were: adult; post-traumatic; with segmental femoral defects; minimum follow-up 1 year; managed under a 2-stage protocol, with an interim antibiotic poly (methyl methacrylate) (PMMA) spacer. Definitive reconstruction was completed with exchange to a 3D printed custom titanium cage filled with bone graft, and stabilized with either an intramedullary (IM) nail or a lateral locked plate. Results: Patient-specific 3D printed titanium cages were used in 5 consecutive patients to reconstruct post-traumatic segmental femoral defects. The mean interval between stages was 100.2 days (83–119 days), the mean defect length was 14.0 cm (10.3–18.4 cm), and the mean bone defect volume measured 192.4 cc (114–292 cc). The mean length of follow-up was 21.8 months (12–33 months). There were no deep infections, fractures, nerve injuries, loss of alignment, or nonunions identified during the period of follow-up. All of the patients achieved union clinically and radiographically. Histology and IHC demonstrated a greater number of vessels, cell nuclei, and extensive staining for cluster of differentiation 68 (CD68), platelet and endothelial cell adhesion molecule 1 (PECAM-1), and vascular endothelial growth factor (VEGF) in the induced membranes compared to local fascia controls. Gene expression analysis revealed significant differential regulation of essential genes involved in inflammatory, angiogenic, and osteogenic pathways [interleukin 6 (IL-6), nuclear factor kappa B1 (NF-κB1), receptor activator of nuclear factor kappa-β ligand (RANKL), vascular endothelial growth factor A (VEGFA), angiogenin (ANG), transforming growth factor, beta 1 (TGF-β1), bone morphogenetic protein-2 (BMP-2), growth differentiation factor 5 (GDF-5), growth differentiation factor 10 (GDF-10), and runt-related transcription factor 2 (RUNX-2)] in the induced membranes. Conclusions: This study demonstrates that the use of a patient-specific 3D printed custom titanium cage, inserted into an induced membrane in a 2-stage protocol, can achieve very acceptable clinical outcomes in selected cases of post-traumatic femoral segmental defects. Patient-specific 3D printed titanium cages, used in conjunction with the Masquelet technique, are a promising new treatment option for managing complex trauma patients with femoral bone loss. Level of Evidence: Level IV (observational case series).

12 July 2022 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
AWAnna Woloszyk
Anna Woloszyk
ZTZewen Tuong
Zewen Tuong
LPLouis Perez
Louis Perez
LALeonardo Aguilar
Leonardo Aguilar
ABAbraham I. Bankole
Abraham I. Bankole
VGVaida Glatt
Vaida Glatt